Dr. Beatriz Mothe, physician and researcher at the Germans Trias Institute, the AIDS Research Institute IrsiCaixa and the Fight AIDS Foundation, has earned one of the 12 "Juan Rodés" postdoctoral aids from the new program of the Carlos III Health Institute of the Ministry of Economy and Competitiveness. The ceremony was held on Friday, March 7.
The Carlos III Institute of Health, the main public institution to fund, manage and execute biomedical research in Spain, published in the summer of 2013 the bases for these new aids for doctors named Juan Rodés, who was CEO of Hospital Clínic of Barcelona (2003-2008) and one of the top drivers and manager of the IDIBAPS (1997-2008), institution in wich he still works today.
Juan Rodes contracts mean, within the State Talent Promotion and its Employability Programme, a new line of recruitment for medical staff with research experience in Science and Health Technologies. Candidates had to have completed the research training program Río Hortega and only accredited Institutes of Health Research have been able to apply for these grants: it is, therefore, a new way to attract and retain talent in these institutes that represent the best of the Spanish translational research. The Juan Rodes are contracts of one year (extendable to a maximum of three) in which the welfare activities of the professionals will take place in accredited hospitals and should be combined with research,
Recipients of these aids have been selected because of their curricular merits and the quality and impact of their scientific proposal. Dr. Mothe belongs to the Fight AIDS Foundation and IrsiCaixa staffs since September 2007. In 2008 he worked in Boston with Dr. Christian Brander's team (current scientific director of the Hivacat program), and in 2011, at the National Cancer Institute (NCI) / National Institutes of Health (NIH), again in the U.S.
La Dra. Mothe forma parte del equipo de la línea de investigación en inmunología y vacunas de la Fundación Lucha contra el Sida, y de la línea de inmunidad celular y genética del huésped en el Instituto de Investigación del Sida IrsiCaixa, trabajando en proyectos de desarrollo de nuevas vacunas del VIH, así como en la coordinación y monitorización de ensayos clínicos de vacunas terapéuticas.
Dr. La Mothe is part of the cellular and genetic host immunity research line in the AIDS Research Institute IrsiCaixa, and of the immunology and vaccines line at the Fight AIDS Foundation. She is working on developing projects of new HIV vaccines, as well as coordinating and monitoring clinical trials of therapeutic vaccines.